Filing Details
- Accession Number:
- 0001209191-21-052881
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-23 08:30:57
- Reporting Period:
- 2021-08-19
- Accepted Time:
- 2021-08-23 08:30:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1735944 | Reshma Kewalramani | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-19 | 5,757 | $195.14 | 69,511 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-19 | 4,243 | $196.34 | 73,754 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Open market purchases reported on this line occurred at a weighted average price of $195.14 (range $194.63 to $195.50).
- Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
- Open market purchases reported on this line occurred at a weighted average price of $196.34 (range $195.74 to $196.58).
Billionaire Hedge Funds
